drugset / Trial / NCT00195585
Study Evaluating Isovorin in Colon Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to verify superiority of 1-LV/5FU therapy to UFT Therapy of relapse-free survival time in patients with Dukes C and Cure A colon cancer. Secondary endpoints include disease-free survival time, survival time, and safety.
Timeline
- Start
- 2002-10
- Primary completion
- 2006-02
- Completion
- 2006-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levoleucovorin | Unknown | — | — |
| Subject | UFT | Unknown | — | — |